Your browser doesn't support javascript.
loading
High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia.
Ortiz Rojas, César Alexander; Costa-Neto, Abel; Pereira-Martins, Diego A; Le, Duy Minh; Sternadt, Dominique; Weinhäuser, Isabel; Huls, Gerwin; Schuringa, Jan Jacob; Magalhães Rego, Eduardo.
Afiliación
  • Ortiz Rojas CA; Department of Medical Images, Hematology and Clinical Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto 14048-900, Brazil.
  • Costa-Neto A; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto 14051-060, Brazil.
  • Pereira-Martins DA; Hematology Division, LIM31, Medical School, University of São Paulo, São Paulo 05403-000, Brazil.
  • Le DM; D'Or Institute for Research and Education (IDOR), São Paulo 04501-000, Brazil.
  • Sternadt D; Hematology Division, LIM31, Medical School, University of São Paulo, São Paulo 05403-000, Brazil.
  • Weinhäuser I; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
  • Huls G; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
  • Schuringa JJ; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
  • Magalhães Rego E; Hematology Division, LIM31, Medical School, University of São Paulo, São Paulo 05403-000, Brazil.
Cancers (Basel) ; 15(1)2022 Dec 31.
Article en En | MEDLINE | ID: mdl-36612292

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza